BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20925909)

  • 21. RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.
    Reinhold WC; Varma S; Sunshine M; Elloumi F; Ofori-Atta K; Lee S; Trepel JB; Meltzer PS; Doroshow JH; Pommier Y
    Cancer Res; 2019 Jul; 79(13):3514-3524. PubMed ID: 31113817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays.
    Guttman M; Mies C; Dudycz-Sulicz K; Diskin SJ; Baldwin DA; Stoeckert CJ; Grant GR
    PLoS Genet; 2007 Aug; 3(8):e143. PubMed ID: 17722985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latent factor analysis to discover pathway-associated putative segmental aneuploidies in human cancers.
    Lucas JE; Kung HN; Chi JT
    PLoS Comput Biol; 2010 Sep; 6(9):e1000920. PubMed ID: 20824128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collective effects of long-range DNA methylations predict gene expressions and estimate phenotypes in cancer.
    Kim S; Park HJ; Cui X; Zhi D
    Sci Rep; 2020 Mar; 10(1):3920. PubMed ID: 32127627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CellMiner: a relational database and query tool for the NCI-60 cancer cell lines.
    Shankavaram UT; Varma S; Kane D; Sunshine M; Chary KK; Reinhold WC; Pommier Y; Weinstein JN
    BMC Genomics; 2009 Jun; 10():277. PubMed ID: 19549304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated metabolome and transcriptome analysis of the NCI60 dataset.
    Su G; Burant CF; Beecher CW; Athey BD; Meng F
    BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S36. PubMed ID: 21342567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying direct miRNA-mRNA causal regulatory relationships in heterogeneous data.
    Zhang J; Le TD; Liu L; Liu B; He J; Goodall GJ; Li J
    J Biomed Inform; 2014 Dec; 52():438-47. PubMed ID: 25181465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic comparison of copy number alterations in four types of female cancer.
    Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
    BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.
    Luna A; Elloumi F; Varma S; Wang Y; Rajapakse VN; Aladjem MI; Robert J; Sander C; Pommier Y; Reinhold WC
    Nucleic Acids Res; 2021 Jan; 49(D1):D1083-D1093. PubMed ID: 33196823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
    Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
    Culhane AC; Perrière G; Higgins DG
    BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
    Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
    Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Exploration of novel molecular targets for cancer therapy based on genomic aberrations].
    Imoto I; Inazawa J
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1891-4. PubMed ID: 16282722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. InterSIM: Simulation tool for multiple integrative 'omic datasets'.
    Chalise P; Raghavan R; Fridley BL
    Comput Methods Programs Biomed; 2016 May; 128():69-74. PubMed ID: 27040832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network-based integration of multi-omics data for prioritizing cancer genes.
    Dimitrakopoulos C; Hindupur SK; Häfliger L; Behr J; Montazeri H; Hall MN; Beerenwinkel N
    Bioinformatics; 2018 Jul; 34(14):2441-2448. PubMed ID: 29547932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Linear Regression and Deep Learning Approach for Detecting Reliable Genetic Alterations in Cancer Using DNA Methylation and Gene Expression Data.
    Mallik S; Seth S; Bhadra T; Zhao Z
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Massive NGS data analysis reveals hundreds of potential novel gene fusions in human cell lines.
    Gioiosa S; Bolis M; Flati T; Massini A; Garattini E; Chillemi G; Fratelli M; Castrignanò T
    Gigascience; 2018 Oct; 7(10):. PubMed ID: 29860514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.